Jun 29
|
Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition
|
Jun 25
|
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
|
Jun 9
|
June 2025's Spotlight On Promising Penny Stocks
|
Jun 9
|
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
|
Mar 16
|
3 Struggling Stocks Down More Than 50% This Year That Look Cheap But Come With Plenty of Risk
|
Feb 27
|
Maravai LifeSciences Holdings, Inc. (MRVI) Acquires Officinae Bio to Enhance AI-Driven mRNA Development
|
Feb 25
|
Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
|
Feb 24
|
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
|
Sep 24
|
TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
|
Aug 29
|
Maravai LifeSciences' Cygnus & TriLink Unveil AccuRes DNA Kits
|
Aug 28
|
Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
|
Jul 29
|
Maravai LifeSciences Appoints Trey Martin to Board of Directors
|
Jun 12
|
Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc
|
May 13
|
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
|
May 10
|
Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
May 9
|
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript
|
May 9
|
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
|
May 9
|
Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ...
|
May 9
|
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript
|
May 8
|
Maravai LifeSciences Reports First Quarter 2024 Financial Results
|